This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

New Gold, Poniard: Early Volume Plays

NEW YORK ( TheStreet) -- Several stocks trading near $5 were poised to move on above-average volume during Monday's session.

Poniard Pharmaceuticals (PARD) said Sunday that its experimental chemotherapy drug picoplatin reduced the severity of nerve damage in patients undergoing treatment for colon cancer, meeting the primary goal of a phase II study.'s Adam Feuerstein notes that Poniard shares rallied 22% Friday ahead of the announcement, which could lead to "sell the news" action Monday. The 50-day average daily volume for Poniard is 4.62 million shares, according to the Nasdaq.

Hansen Medical (HNSN - Get Report) shares should open lower Monday after the company late Friday announced a $65 million mixed securities shelf offering. The 50-day average daily volume for Hansen is 494,000 shares. The stock closed Friday at $2.90.

Antigenics (AGEN - Get Report) should trade lower Monday after the company announced Friday at $100 million mixed securities shelf offering. The 50-day average daily volume for Antigenics is 1 million shares. Shares ended trading Friday at 81 cents.

New Gold (NGD - Get Report) may trade higher Monday after the company said it expects annual gold production to increase to 330,000 to 360,000 ounces in 2010 from 301,773 ounces in 2009. The total cash cost in 2009 is expected to fall between $445 to $465 per ounce sold, New Gold said, compared to $462 in 2009. The three-month average daily volume for New Gold is 2.78 million shares, according to Yahoo! Finance. Shares closed Friday at $4.20.

-- Written by Robert Holmes in Boston.

Check out all of Monday's high-volume, under-$5 stocks at the Dollar Store

Follow Robert Holmes on Twitter and become a fan of on Facebook.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AGEN $3.05 -1.90%
HNSN $4.06 1.50%
NGD $4.72 7.50%
PARD $0.12 0.00%
AAPL $92.82 -0.45%


Chart of I:DJI
DOW 17,651.43 -9.28 -0.05%
S&P 500 2,041.82 -8.81 -0.43%
NASDAQ 4,690.20 -26.8940 -0.57%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs